Diovan® receives EU approval for the treatment of heart attack survivors
Mon, 09 May 2005 04:00 AM EST
... Leading antihypertensive agent Diovan is first in its class to receive approval to treat people after heart attacks; also being evaluated in EU to treat heart failure - Novartis announced today that it has successfully completed the EU Mutual Recognition Procedure (MRP) in 14 countries for Diovan® (valsartan) for the treatment of heart attack survivors... click link for more info. ...
Related Topics
- Heart Attack
- Terrorist Attacks
- Heart Disease
- Panic Disorder
- Stroke
- Angina
- Congestive Heart Failure
- Coronary Heart Disease
- Heart Murmur
- Heart Diseases
- Congenital Heart Disease
- Heart Defects
- Heart and Circulation
- Heart Bypass Surgery
- Coronary Disease
- Heart Diseases--Prevention
- Heart Valve Diseases
- Risk Factors
- Vaccine Testing & Approval
- Periodontal Disease

Not Signed In -


